TIL Therapy Combined With Pembrolizumab for Advanced Brain Cancer Including Gliomas and Meningiomas

Clinical trial NCT06640582 · RECRUITING

Trial details

NCT number: NCT06640582
Sponsor: Essen Biotech
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Brain Tumor Brain Metastases Brain Cancer Glioma Gliomas, Malignant Glioblastoma Meningioma

Start date: 2024-10-20
Primary completion: 2026-09-10
Enrollment: 85

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.